Journal of Advances in Leukemia

Aims and Scope

The Journal of Advances in Leukemia (JAL) is an open access and peer reviewed journal that focuses on providing the latest discoveries, findings and advancements in the field of leukemia and its subtypes/diseases in the diagnostic, experimental and clinical setting. The journal also welcomes articles related to the diagnosis and management of leukemia.

The Journal of Advances in Leukemia (JAL) is to accelerate research and developments in leukemia and to promote the exchange of ideas between researchers and clinicians. The scope of the journal is restricted to the study of leukemia and related subtypes/diseases. Thus, articles on advances in acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, and pediatric leukemia are included in the journal's scope. Basic research, translational research and clinical studies related to leukemia are also welcome.

JAL is committed to providing a platform for the exchange of knowledge on the biology and treatment of all forms of leukemia. This includes the study of cellular, molecular and genetic mechanisms of leukemia as well as the discovery of new therapies and biomarkers that can be used for the diagnosis and treatment of leukemia. The journal also encourages submissions on the clinical aspects of leukemia, such as the systematic follow-up of patients and the management of relapsed and refractory disease.

The ultimate goal of JAL is to foster new ways of thinking and uncover novel discoveries in the field of leukemia and related diseases. It is our hope that through this journal, we can continue to expand the scientific knowledge base and improve the outcomes for patients suffering from leukemia.

Below is the list of topics this journal covers. However, if you could not find the topic of your interest Please feel free to contact us at [email protected]

• Anemia
• Lymphoma
• Basal cell carcinoma
• Multiple Myeloma
• Thalassemia
• Aplastic anemia
• Prognosis
• Hodgkin’s lymphoma
• Adenocarcinoma
• Hematology
• Myelodysplastic syndrome
• Acute Myeloid Leukemia
• Blood Cancer
• Biochemistry
• Blood-transfusion
• Acute Lymphoblastic Leukemia
• Coagulation
• B-cell-lymphoma
• Chronic Lymphocytic Leukemia
• Non Hodgkin Lymphoma
• Chronic Myeloid Leukemia
• Acute leukemia
• T cell lymphoma
• Hairy Cell Leukemia
• Oncogene
• Cell biology
• Serum protein electrophoresis
• Myelodysplastic syndromes
• Chronic Myelogenous Leukemia
• Leukemia Diagnosis
• Myelodysplastic
• Lymph node biopsy
• Multiple Myleoma
• Acute Myelogenous Leukemia
• Stem Cell Transplantation
• Chronic myelomonocytic leukemia
• Myelogenous-leukemia
• Hematopoietic Stem Cell Transplantation
• Hematologic Malignancies
• Plasma cell leukemia
• Bone Marrow Transplantation
• Plasma cell myeloma
• Lymphoproliferative disorders
• Acute Myeloblastic Leukemia
• Hematological-malignancies
• Hematological Malignancies
• Leukemia Prevention
• Myeloproliferative-diseases
• Immunobiology
• Transfusion Medicine
• Multifocal-leukoencephalopathy
• Leukemia Research
• Non Hodgkin's Disease
• Chronic Myelogenous Leukemia (CML)
• Adult Acute Lymphoblastic Leukemia
• Chemotheraphy
• Erythroleukemia
• Acute erythroid leukemia
• Childhood Acute Lymphoblastic Leukemia
• Chains of Hemoglobin
• Vascular biology
• Leukocytes and platelets
• Adenoid cystic cancer
• Adult Acute Myeloid Leukemia
• Lymphoma Research